Guardion Health Sciences, Inc.
GHSIHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $12.2M | $11.0M | $7.2M | $1.9M | $902,937 | $942,153 |
| Operating income | −$4.3M | −$17.4M | −$24.7M | −$8.6M | −$10.5M | −$6.1M |
| Net income | $158,033 | −$14.9M | −$24.7M | −$8.6M | −$10.9M | −$7.8M |
| Total assets | $11.9M | $21.7M | $23.5M | $9.9M | $12.9M | $3.7M |
| Total liabilities | $3.8M | $8.5M | $1.2M | $1.3M | $844,981 | $495,337 |
| Equity | $8.1M | $7.9M | $22.3M | $8.5M | $12.0M | $3.2M |
| EPS (diluted) | $0.12 | $-14.15 | $-52.23 | — | — | — |
| Shares out. | 1.3M | 61.4M | 24.4M | 85.3M | 20.6M | 40.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −35.4%
- Net margin
- 1.3%
- Return on equity
- 1.9%
- Return on assets
- 1.3%
- Return on capital (ROCE)
- −40.9%
- Liabilities / assets
- 31.7%
- Debt / equity
- 0.46×
- Book value / share
- $6.43
- Revenue growth (YoY)
- 10.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -19.96distress
- Accruals / assets
- 38.0%high accruals
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 3, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Great Point Capital LlcPassive (13G)May 23, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Material events
SEC Form 8-K · most recent- Director / officer change · Other material eventDec 26, 2024
- Director / officer change · Amended charter or bylawsNov 18, 2024
- Other material eventOct 31, 2024
- Delisting / listing-standard notice · Director / officer changeOct 3, 2024
- Director / officer changeSep 23, 2024
- Other material eventAug 21, 2024
- Results of operationsAug 14, 2024
- Director / officer changeJul 15, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- EFFECTJan 24, 2025
- 15-12GJan 23, 2025
- S-8 POSJan 23, 2025
- POS AMJan 23, 2025
- 8-KDec 26, 2024
- 8-KNov 18, 2024
- SC 13G/AGHSI 13G/ANov 8, 2024
- 8-KOct 31, 2024
- 25Oct 11, 2024
- 8-KOct 3, 2024
- 8-KSep 23, 2024
- 4OWNERSHIP DOCUMENTAug 28, 2024
- SC 13G/AAMENDMENT NO. 2 TO SCHEDULE 13GAug 28, 2024
- 144Aug 26, 2024
- 8-KAug 21, 2024
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.